Chairman and CEO Peter Derycz Contributes Articles on Streamlining the FDA Approval Process to Two Leading Pharmaceutical Industry Journals

SANTA MONICA, Calif., March 18 /PRNewswire-FirstCall/ -- Peter Derycz, Chairman and CEO of Derycz Scientific, Inc., (OTC Bulletin Board: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, has contributed articles to the journals Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News.  Both articles discuss the ways that a dedicated professional document preparation service, like the kind provided by Derycz subsidiary Reprints Desk, Inc., can contribute to timely regulatory submissions and approvals for pharmaceutical companies.

The Pharmaceutical Manufacturing article is titled "Speeding Approval in the Era of Electronic Submissions" and is currently online.  The Genetic Engineering & Biotechnology News article is titled "Navigating Electronic Submissions:  Specialized Software and Document-Preparation Services Can Streamline Process" and is datelined March 15th.

In the articles, Mr. Derycz notes that the FDA has mandated that all electronic submissions adhere to the electronic Common Technical Document (eCTD) format, which is emerging as a global industry standard.  This format poses distinct challenges for pharmaceutical companies, since the scientific literature is not created in this format.  He writes that the necessary published literature for the regulatory approval process can be effectively standardized and facilitated by a dedicated professional document preparation service.  Such a service will not only have specialized expertise in manufacturing information and electronic resources, but will also have a thorough familiarity with both the eCTD format and current copyright laws.

Mr. Derycz commented:  "In these articles I have expressed my belief that dedicated document preparation services play an important role in getting new drugs to market faster.  By smoothing the path to drug approval and minimizing the timeframe involved, pharmaceutical companies and their customers will ultimately reap greater benefits."

To read the Pharmaceutical Manufacturing article online, please visit:

http://www.pharmamanufacturing.com/articles/2010/031.html.

To read the Genetic Engineering & Biotechnology News article online, please visit:

http://www.genengnews.com/articles/chitem.aspx?aid=3227.

About Derycz Scientific®

Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com

SOURCE Derycz Scientific, Inc.

Back to top

RELATED LINKS
http://www.deryczscientific.com/